Investing.com - Financial Markets Worldwide
Get 40% Off
Get 40% Off
⚠ Earnings Alert! Which stocks are poised to surge?
See the stocks on our ProPicks radar. These strategies gained 19.7% year-to-date.
Unlock full list

Zynerba Pharmaceuticals Inc (ZYNE-RM)

Moscow
Currency in RUB
Disclaimer
121.00
0.00(0.00%)
Real-time Data

ZYNE-RM Comments

6.9 at the eow and i will be happy
wishful thinking
good month
Lots of movement recently. I think there is future in theirs transdermal drug.
you betta hold this support zyne or ill be angry xD
Premarket surge. Whats the reason? Jump off b4 earnings?
nvm its gone ;D
Recommendation No 1: Avoid sh... companies like this one!
volume spik but candel does not look like bulls were winners.
Did any1 try cdb cakes? I read fragments of Zynerba article stating that cdb in acid environment as stomach convert to thc
Now I see that Zynerba statement about cbd degradation to thc in acid environment has been questioned: about degradation https://www.liebertpub.com/doi/pdfplus/10.1089/can.2015.0004 contra https://www.liebertpub.com/doi/pdf/10.1089/can.2016.0036
Green next week
Which target?
Very soon it will up to *******
When $3 I get in.
I bought 20k in shares yesterday when the price fell to $8.31.... just in few minutes i sold when it reached $9.31 I made 12% in less than one hour. Easy, clean and honest money. It will soon, reach back to $12 a share Now I am waiting for Nio to drop to $2.80, that will probably happen on friday. Then next week I will sell it for above $3,5
Corporate malfeasance!!
earnings target?
Buy Buy good move this week
I haven't wanted to give up on it but I think that's about to change. I'm down 17.39%since purchasing and I don't see any light at the end of the tunnel.
easy man. I had opened long cfd on cron with 21.7 and now im down almost 45% on this position so... I opened second long on 16.4 and than third on 14.50. And Im holding all of them. Patience is the key imo so I will wait as long as it needs to be.
keep or sell?
both
This is revolutionizing how CBD is applied, in a market flourishing with demand on both the medical and recreational fronts. I wouldn’t buy now, but definitely recommend entering at next pull back to ~$12-$13, in order to yield gains through $20. Hopefully FDA approval follows shortly and confirm an excellent long opportunity. I entered at $5. Bullish!
ZYNE is a long term investment stock, itll continue fluctuating; you just need the patience until they get the treatment FDA approved and commercially distributed, thats when the real money will be made.
It needs time U can make small amount of money buying and selling within the daily range
Kept my etes in this for months and missed the spike smh now its too late to jump in
I was in the same boat. sold in February. Horrible move. *****me seeing it *******it right now. It's absolutely blowing up. Patience, patience, patience....I need more!!ugh
I love ZYNE and everyone in here!!! Well positioned in an industry expecting several major catalysts! Bullish!
I love this ZYNE and everyone in here!!!
One good thing about Cannabis stock is that it can go up 20% in one day.. Never doubt about it
Bullish!!!
love it!!
ZYNE keep going!!
...
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.